Report 2021, Central Nervous System Treatment Market Size, Share, Growth, Trends, Analysis, Revenue, Forecast Report – 2020-2027
Key Prominent Players Covered in the Central Nervous System Treatment Market Research Report Are Eli Lilly and Company, Pfizer Inc., Otsuka America Pharmaceutical, Inc., Biogen, AstraZeneca, Novartis AG, Takeda, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc. and other key market players.
Pune, India, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The global central nervous system treatment market size is expected to gain momentum in the forthcoming years. This is attributable to the increasing prevalence of neurological disorders and the availability of advanced healthcare facilities in developed and emerging economies that propel the adoption of novel central nervous system treatment solutions globally.
The central nervous system (CNS) is a vital system of the human body that controls major functions of the body and mind. It primarily has three significant functions that include information processing, sensory input, and motor output. The failure of CNS leads to several adverse health effects such as memory loss, weakness, numbness, lack of coordination, and loss of sight, among others. However, to counter this condition, several central nervous system treatment options are in the offing across the healthcare facilities worldwide.
*
*
*Request a Sample Copy of the Research Report: *https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/central-nervous-system-treatment-market-103973
*
*
*Increasing Incidence of Neurological Disorders to Feed Market Growth*
According to the World Health Organization (WHO), around 1.2 million adult-onset brain disorders diagnosed are due to Alzheimer disease. Additionally, over 60,000 Americans are diagnosed with Parkinson’s disease in the United States. The increasing prevalence of neurological disorders is expected to boost the adoption of advanced central nervous system treatment solutions during the forecast period. Moreover, availability of advanced healthcare facilities is expected to contribute to the global central nervous system treatment market in the forthcoming years.
*Growing Pharmaceutical Sector in North America to Accelerate Growth*
Among all the regions, North America is expected to remain dominant and hold the highest position in the global central nervous system treatment market during the forecast period. This dominance is attributable to the growing pharmaceutical sector that supports the adoption of advanced central nervous system treatment solutions in the region.
The widespread effect of the global pandemic, COVID-19, has been felt across several economies that are facing unprecedented loss. Owing to the lockdown announced by the government agencies, several industries have been on a standstill with limited operational activities. However, a collective effort from the government as well as the industries is likely to bring the economy back on track and aid in the resumption of industrial activities.
*
*
*Click here to get the short-term and long-term impact of COVID-19 on this Market.*
*Please visit:* https://www.fortunebusinessinsights.com/central-nervous-system-treatment-market-103973
On the other hand, Europe is expected to hold the second position in the market owing to the increasing demand for therapeutic drugs in the region between 2020 and 2027.
*Increasing Investment in R&D Activities by Prominent Companies to Boost Product Adoption*
The global central nervous system treatment market is consolidated by the presence of major companies that are investing in R&D activities to develop novel central nervous system treatment solutions. Additionally, other key players are adopting strategies such as collaborations and partnerships that are likely to bode well for the market growth during the forecast period.
*Industry Development:*
· *December 2020 – *Innovent Biologics, Inc., a leading biopharmaceutical company, announced the approval of its recombinant humanized anti-VEGF monoclonal antibody drug, BYVASDA by the National Medical Products Administration (NMPA) of China. The company reports that the central nervous system treatment solution is an effective therapeutic drug that can be used for treating glioblastoma patients.
*
*
*Quick Buy - Central Nervous System Treatment Market Research Report: *https://www.fortunebusinessinsights.com/checkout-page/103973
*
*
*List of the Companies Profiled in the Global Market for Central Nervous System Treatment:*
· Eli Lilly and Company
· Pfizer Inc.
· Otsuka America Pharmaceutical, Inc.
· Biogen
· AstraZeneca
· Novartis AG
· Takeda
· Merck & Co., Inc.
· Teva Pharmaceutical Industries Ltd.
· Johnson & Johnson Services, Inc.
· Others
*
*
*Have Any Query? Ask Our Experts: *https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/central-nervous-system-treatment-market-103973
*
*
*Global Central Nervous System Treatment Market Segmentation*
By Drug Class
• Analgesics
• Anesthetics
• Anticonvulsants
• Antiemetics
• Antiparkinson Agents
• Others
By Disease Indication
• Neurovascular Disease
• Degenerative Disorders
• Mental Health & Trauma
• Others
By Distribution Channel
• Hospitals Pharmacy
• Retail Pharmacy
• Online Pharmacy
By Geography
• North America (USA, Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
*
*
*Get your Customized Research Report: *https://www.fortunebusinessinsights.com/enquiry/customization/central-nervous-system-treatment-market-103973
*
*
*SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:*
· Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
· Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
· Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
· Number of procedures and average price of procedures
· Replacement rate and pricing of capital equipment
· Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
· Market & technological trends, new product developments, product pipeline.
*
*
*Have a Look at Related Reports:*
Psoriatic Arthritis Treatment Market Share and Global Trend By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies) and Geography Forecast till 2026
Hiv/Aids Drugs Market Share and Global Trend By Drug Class (Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Integrase Inhibitors, Combination HIV Medicines, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Geography Forecast Till 2026
Autism Spectrum Disorder Therapeutics Market Share and Global Trend By Type (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, Others), By Treatment Type (Communication & Behavioral Therapies, Drug Therapies) and Geography Forecast till 2026
Revenue Cycle Management Market Share and Global Trend By Structure (In-house Outsource) By Function (Claims & Denial Management, Medical Coding & Billing, Clinical Documentation Improvement (CDI), Insurance, Others) By Type (Software, Services) and Geography Forecast till 2026
ePharmacy Market Share and Global Trend By Product (Over-the-Counter Products, Prescription Medicine) and Geography forecast till 2026
*
*
*About Us:*
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
*Contact Us:*
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
*Phone:*
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs